权益投资(Equity Investments)
一、本课定位
| 课次 | 主题 | 能力 |
|---|---|---|
| L344 | 行业与公司分析测试讲评 | 能够运用行业生命周期、竞争优势、波特五力、SWOT、财务比率及估值模型对具体行业和公司进行综合分析,并准确识别常见概念陷阱 |
二、我们要解决什么问题?
某考生在做权益投资模块题目时,面对“某公司处于行业生命周期的成长期,毛利率持续上升但净利率下降,同时面临新进入者威胁”,无法快速判断其竞争优势可持续性及合理估值倍数,导致选择题错误率高达65%。本课通过系统梳理行业与公司分析的核心框架、关键财务指标、估值方法,并结合3个完整案例和8道高频考题,帮助考生彻底掌握如何将定性行业分析与定量财务、估值分析融会贯通,解决考试中最容易混淆的综合应用问题。
三、行业分析的核心框架
行业分析是权益投资自上而下方法的第一步,主要回答“这个行业是否值得投资”。CFA一级重点考察三个工具:
- 行业生命周期(Industry Life Cycle)
- 幼年期(Embryonic):销售增长慢、投资大、现金流为负、高风险
- 成长期(Growth):销售高速增长、利润率上升、竞争加剧
- 成熟期(Mature):增长稳定、利润率最高、竞争最激烈
- 衰退期(Decline):销售下降、产能过剩、利润率压缩
不同阶段的ROE、资本支出、股利支付率差异显著,是判断估值倍数(P/E、EV/EBITDA)的重要依据。
- 波特五力模型(Porter’s Five Forces)
- 现有竞争者 rivalry
- 新进入者威胁 threat of new entrants
- 替代品威胁 threat of substitutes
- 供应商议价能力 supplier power
- 买方议价能力 buyer power
五力越强,行业长期ROE越接近加权平均资本成本(WACC),竞争优势越难维持。
- 竞争优势与经济护城河(Economic Moat)
高壁垒行业(如制药、消费品)可长期维持ROE > WACC。常见护城河:品牌、规模经济、网络效应、专利、监管壁垒。
四、公司分析的核心工具
在选定行业后,需对具体公司进行微观分析:
- SWOT分析:Strengths、Weaknesses、Opportunities、Threats
- 财务比率全面解读(重点掌握趋势与同业比较)
- 盈利能力:Gross Margin, Operating Margin, Net Margin, ROE (DuPont: PM × AT × EM)
- 流动性:Current Ratio, Quick Ratio
- 杠杆:Debt-to-Equity, Interest Coverage
-
效率:Inventory Turnover, Receivables Turnover, Asset Turnover
-
可持续增长率(Sustainable Growth Rate)
$$ g = ROE \times (1 - \text{Dividend Payout Ratio}) $$
若实际增长率长期高于可持续增长率,公司需外部融资或杠杆上升,风险增加。
五、公司估值方法在行业分析中的应用
- 相对估值法
- P/E、P/B、EV/EBITDA
-
调整因素:增长率、ROE、风险(β)、利润率趋势
-
绝对估值法(DDM与FCFF)
高增长阶段用两阶段或三阶段模型,成熟阶段趋向Gordon增长模型:
$$ P_0 = \frac{D_1}{r - g} = \frac{E_1 \times (1-b)}{r - g} $$
其中 $b$ 为留存比率,$g = b \times ROE$。
完整案例演算
案例 1:行业生命周期对估值倍数的影响
某消费电子公司处于成长期,预计未来3年EPS增长率25%,之后进入成熟期永续增长率4%。当前EPS = 2.0元,派息率成长期20%、成熟期60%,要求回报率r=10%。计算当前合理P/E(前向)。
解答:
第一阶段(高增长3年):
D1 = 2.0×1.25×0.2 = 0.5
D2 = 0.5×1.25 = 0.625
D3 = 0.625×1.25 = 0.78125
成熟期第4年:E4 = 2.0×(1.25)^3×1.04 ≈ 4.096
D4 = 4.096×0.6 ≈ 2.458
终端价值P3 = 2.458 / (0.10 - 0.04) = 40.96
现值:
PV(D1) = 0.5/1.1 = 0.455
PV(D2) = 0.625/1.21 ≈ 0.517
PV(D3) = 0.78125/1.331 ≈ 0.587
PV(P3) = 40.96/1.331 ≈ 30.77
股权价值 ≈ 0.455+0.517+0.587+30.77 = 32.33
当前股价 ≈ 32.33,合理前向P/E = 32.33 / (2.0×1.25) ≈ 12.93倍。
案例 2:波特五力与ROE可持续性
制药行业现有5家龙头企业,专利保护强,研发壁垒高,买方(医院)分散,替代品威胁低。过去10年行业平均ROE 22%,WACC 9%。判断该行业长期经济利润能否持续,并说明理由。
解答:
五力整体较弱(专利形成进入壁垒,现有竞争者因专利分隔市场),护城河明显。因此ROE可长期维持在22% > WACC 9%,公司能持续创造正经济利润(EVA>0)。若专利 cliff 大量到期,则新进入者威胁上升,ROE将向WACC回归。
案例 3:杜邦分析与可持续增长率
某公司2023年数据:净利润率8%,总资产周转率1.25,权益乘数2.0,派息率40%。
计算:(1) ROE;(2) 可持续增长率;(3) 若实际增长率15%,公司财务政策是否可持续?
解答:
(1) ROE = 8% × 1.25 × 2.0 = 20%
(2) 留存比率 = 1-0.4 = 0.6,可持续增长率 g = 20% × 0.6 = 12%
(3) 实际增长15% > 12%,不可持续,需提高杠杆、提高利润率或降低派息率,否则将消耗现金或增加债务风险。
易错陷阱对照
| 易错点 | 错误做法 | 正确做法 |
|---|---|---|
| 生命周期阶段判断 | 仅看销售增长率 | 需结合利润率趋势、资本支出、竞争强度综合判断 |
| 波特五力误用 | 把“行业增长快”当成五力之一 | 五力只分析结构因素,增长是生命周期内容 |
| ROE高就一定好 | 认为ROE>20%公司一定值得买 | 必须比较ROE与WACC,关注ROE是否可持续 |
| P/E倍数直接比较 | 不同生命周期公司直接比P/E | 成长期公司合理P/E显著高于成熟期 |
| 可持续增长率计算 | 忘记用留存比率×ROE | g = ROE × retention ratio,必须与实际增速对比 |
| 护城河判断 | 只看当前毛利率 | 重点看能否长期维持ROE > WACC |
关键公式 / 关系速记
- ROE(杜邦)= 净利润率 × 总资产周转率 × 权益乘数
- 可持续增长率 $g = ROE \times (1 - \text{派息率})$
- Gordon增长模型 $P_0 = \frac{D_1}{r-g}$
- 前向P/E与增长、ROE关系:合理P/E ≈ $\frac{(1-b)(1+g)}{r-g}$
- 经济利润 = NOPAT – WACC × 资本总额(正值说明创造价值)
练习题(含计算与情景)
Q1. 处于幼年期的行业最不可能出现的特征是:
A. 高额研发支出
B. 负的自由现金流
C. 较高的股利支付率
D. 较高的经营风险
Q2. 根据波特五力分析,当以下哪种情况发生时,行业长期平均ROE最可能下降?
A. 专利保护期延长
B. 主要原材料供应商集中度提高
C. 产品差异化程度显著提升
D. 行业内现有企业数量从8家减少到4家
Q3. 某公司ROE=18%,派息率=30%,WACC=11%。其可持续增长率最接近:
A. 5.4%
B. 12.6%
C. 18.0%
D. 30.0%
Q4. 在使用相对估值法时,对成长期公司最合适的调整是:
A. 给予更高EV/EBITDA倍数
B. 给予更低P/B倍数
C. 忽略增长率差异
D. 只比较历史P/E
Q5. 以下哪项最能表明公司拥有强大经济护城河?
A. 当前毛利率高于行业平均
B. 过去10年ROE持续显著高于WACC
C. 资产周转率高于同行
D. 流动比率大于2
Q6. 某公司当前EPS=4元,预计未来两年增长率20%,之后永续增长5%,派息率高增长期25%、永续期70%,要求回报率12%。其合理当前P/E( trailing)最接近:
A. 12.5倍
B. 15.8倍
C. 18.2倍
D. 21.4倍
Q7. 以下关于行业生命周期的说法错误的是:
A. 成熟期通常有最高的利润率
B. 衰退期资本支出通常低于折旧
C. 成长期ROE通常持续上升
D. 幼年期公司通常采用高派息政策
Q8. 当买方议价能力很强时,最可能导致的结果是:
A. 行业进入壁垒提高
B. 行业平均毛利率被压缩
C. 供应商议价能力同步上升
D. 替代品威胁自动下降
答案与详解
| 题号 | 答案 | 详解 |
|---|---|---|
| Q1 | C | 幼年期公司通常不支付或支付极低股利,需保留现金用于研发和扩张 |
| Q2 | B | 供应商集中度提高→供应商议价能力上升→五力增强→长期ROE下降 |
| Q3 | B | g = 18% × (1-0.3) = 12.6% |
| Q4 | A | 成长期公司增长更快,合理EV/EBITDA倍数应高于成熟期公司 |
| Q5 | B | 经济护城河的核心是长期维持ROE显著高于资本成本 |
| Q6 | B | 计算得股权价值约63.2元,trailing P/E = 63.2/4 ≈ 15.8倍 |
| Q7 | D | 幼年期公司通常零股利或极低派息率,保留资金用于增长 |
| Q8 | B | 买方议价能力强会压低销售价格,直接压缩行业毛利率 |
本节要点速记
- 行业分析必须将生命周期、五力模型、护城河三者结合使用
- ROE必须与WACC比较才能判断是否创造价值
- 可持续增长率是判断公司增长是否健康的“试金石”
- 不同生命周期的公司合理估值倍数差异极大,不可直接比较
- 财务比率分析要看趋势、同业、与生命周期特征是否匹配
- 护城河的核心是“长期维持超额回报的能力”而非短期高利润率
Equity Investments
I. Lesson Focus
This lesson integrates industry life-cycle analysis, Porter’s Five Forces, economic moat evaluation, DuPont decomposition, sustainable growth rate, and both relative and absolute valuation methods. Candidates learn to combine qualitative industry structure with quantitative financial and valuation metrics to solve integrated equity analysis problems.
II. The Problem
A candidate facing a vignette describing a firm in the growth stage with rising gross margins but falling net margins and increasing threat of new entrants cannot determine the sustainability of competitive advantage or the appropriate valuation multiple. This leads to high error rates (approximately 65 %) on integrated items. The lesson provides a systematic framework, three full worked cases, and eight high-frequency exam-style questions to master the fusion of qualitative and quantitative analysis required at Level I.
III. Core Framework of Industry Analysis
Industry analysis is the first step in the top-down equity valuation approach and answers whether the industry is worth investing in. CFA Level I emphasizes three tools.
- Industry Life Cycle
- Embryonic: slow sales growth, heavy investment, negative cash flow, high risk.
- Growth: rapid sales growth, rising profit margins, intensifying competition.
- Mature: stable growth, peak profit margins, most intense competition.
- Decline: falling sales, excess capacity, compressed margins.
ROE, capital expenditure, and dividend payout ratios differ markedly across stages and are critical for selecting appropriate valuation multiples (P/E, EV/EBITDA).
- Porter’s Five Forces
- Rivalry among existing competitors
- Threat of new entrants
- Threat of substitutes
- Bargaining power of suppliers
- Bargaining power of buyers
The stronger the five forces, the closer long-run industry ROE moves toward WACC and the harder it is to sustain a competitive advantage.
- Competitive Advantage and Economic Moat
Industries with high barriers (pharmaceuticals, branded consumer goods) can sustain ROE > WACC for extended periods. Common moats include brand strength, economies of scale, network effects, patents, and regulatory barriers.
IV. Core Tools of Company Analysis
After selecting an attractive industry, micro-analysis of individual firms is required.
- SWOT Analysis: Strengths, Weaknesses, Opportunities, Threats.
- Comprehensive Financial Ratio Analysis (focus on trends versus peers)
- Profitability: Gross Margin, Operating Margin, Net Margin, ROE (DuPont: PM × AT × EM)
- Liquidity: Current Ratio, Quick Ratio
- Leverage: Debt-to-Equity, Interest Coverage
-
Efficiency: Inventory Turnover, Receivables Turnover, Asset Turnover
-
Sustainable Growth Rate
$$ g = ROE \times (1 - \text{Dividend Payout Ratio}) $$
If actual growth persistently exceeds sustainable growth, the firm must raise external capital or increase leverage, raising risk.
V. Valuation Methods in Industry and Company Analysis
- Relative Valuation
- P/E, P/B, EV/EBITDA
-
Adjustments required for differences in growth, ROE, risk (beta), and margin trends.
-
Absolute Valuation (DDM and FCFF)
Multi-stage models are used for high-growth phases; mature stages converge to the Gordon growth model:
$$ P_0 = \frac{D_1}{r - g} = \frac{E_1 \times (1-b)}{r - g} $$
where $b$ is the retention ratio and $g = b \times ROE$.
Worked Cases
Case 1: Impact of Industry Life Cycle on Valuation Multiples
A consumer electronics firm is in the growth stage. EPS is expected to grow at 25 % for the next three years, then enter a mature stage with a perpetual 4 % growth rate. Current EPS = 2.0, payout ratio = 20 % in high-growth and 60 % in mature stage, required return r = 10 %. Calculate the justified forward P/E.
Solution:
High-growth dividends:
D1 = 2.0 × 1.25 × 0.2 = 0.5
D2 = 0.5 × 1.25 = 0.625
D3 = 0.625 × 1.25 = 0.78125
Year-4 earnings: E4 = 2.0 × (1.25)^3 × 1.04 ≈ 4.096
D4 = 4.096 × 0.6 ≈ 2.458
Terminal value at t=3: P3 = 2.458 / (0.10 – 0.04) = 40.96
Present values:
PV(D1) = 0.5 / 1.1 ≈ 0.455
PV(D2) = 0.625 / 1.21 ≈ 0.517
PV(D3) = 0.78125 / 1.331 ≈ 0.587
PV(P3) = 40.96 / 1.331 ≈ 30.77
Total equity value ≈ 32.33. Justified forward P/E = 32.33 / (2.0 × 1.25) ≈ 12.93×.
Case 2: Porter’s Five Forces and ROE Sustainability
The pharmaceutical industry has five dominant firms, strong patent protection, high R&D barriers, fragmented buyers (hospitals), and low substitute threat. Average ROE over the past 10 years is 22 %, WACC = 9 %. Determine whether long-run economic profit can be sustained and explain.
Solution:
Overall five forces are weak (patents create entry barriers and segment markets). The clear moat allows ROE to remain at 22 % > WACC 9 % for a prolonged period, generating positive economic value added (EVA > 0). If a large patent cliff occurs, threat of entry rises and ROE will converge toward WACC.
Case 3: DuPont Analysis and Sustainable Growth Rate
A firm reports net profit margin = 8 %, asset turnover = 1.25, equity multiplier = 2.0, payout ratio = 40 %. Calculate (1) ROE, (2) sustainable growth rate, (3) whether 15 % actual growth is sustainable.
Solution:
(1) ROE = 8 % × 1.25 × 2.0 = 20 %
(2) Retention ratio = 1 – 0.4 = 0.6; g = 20 % × 0.6 = 12 %
(3) Actual growth (15 %) > sustainable growth (12 %), therefore unsustainable. The firm will need higher leverage, improved margins, or a lower payout ratio, otherwise cash will be depleted or debt risk will rise.
Traps
| Common Mistake | Incorrect Approach | Correct Approach |
|---|---|---|
| Life-cycle stage identification | Rely solely on sales growth | Combine profit-margin trend, capex intensity, and competitive pressure |
| Misapplication of Porter’s Five Forces | Treat “fast industry growth” as one of the five forces | Five Forces analyze only structural factors; growth belongs to life-cycle analysis |
| High ROE automatically attractive | Buy any firm with ROE > 20 % | ROE must exceed WACC and be sustainable |
| Direct P/E comparison | Compare P/E across different life-cycle stages without adjustment | Growth-stage firms legitimately command higher P/E than mature firms |
| Sustainable growth rate calculation | Forget retention ratio | g = ROE × retention ratio; always compare with actual growth |
| Moat assessment | Focus only on current gross margin | Core test is ability to sustain ROE > WACC over many years |
Key Formulas
- DuPont ROE = Net Profit Margin × Asset Turnover × Equity Multiplier
- Sustainable growth rate $g = ROE \times (1 - \text{payout ratio})$
- Gordon growth model $P_0 = \frac{D_1}{r-g}$
- Justified leading P/E ≈ $\frac{(1-b)(1+g)}{r-g}$
- Economic profit = NOPAT – (WACC × Invested Capital)
Practice Questions
Q1. The feature least likely to be observed in an embryonic-stage industry is:
A. High R&D spending
B. Negative free cash flow
C. High dividend payout ratio
D. High business risk
Q2. According to Porter’s Five Forces, which development is most likely to reduce long-run industry ROE?
A. Extension of patent protection periods
B. Increased concentration among key raw-material suppliers
C. Significant increase in product differentiation
D. Reduction of existing competitors from eight to four firms
Q3. A company has ROE = 18 %, payout ratio = 30 %, and WACC = 11 %. Its sustainable growth rate is closest to:
A. 5.4 %
B. 12.6 %
C. 18.0 %
D. 30.0 %
Q4. When applying relative valuation, the most appropriate adjustment for a growth-stage company is to assign:
A. A higher EV/EBITDA multiple
B. A lower P/B multiple
C. No adjustment for growth differences
D. Only historical P/E ratios
Q5. Which indicator most clearly signals a strong economic moat?
A. Current gross margin above industry average
B. ROE persistently and significantly above WACC for the past 10 years
C. Asset turnover higher than peers
D. Current ratio greater than 2
Q6. A firm reports current EPS = 4, expected growth of 20 % for two years, then perpetual 5 % growth. Payout ratio = 25 % in high-growth, 70 % in perpetuity; required return = 12 %. The justified trailing P/E is closest to:
A. 12.5×
B. 15.8×
C. 18.2×
D. 21.4×
Q7. Which statement about the industry life cycle is least accurate?
A. The mature stage typically shows the highest profit margins
B. Capital expenditure is usually below depreciation in the decline stage
C. ROE usually continues to rise in the growth stage
D. Embryonic-stage firms typically adopt high dividend-payout policies
Q8. When buyer bargaining power is strong, the most likely result is:
A. Higher industry entry barriers
B. Compression of industry average gross margins
C. Simultaneously higher supplier power
D. Automatic reduction in substitute threat
Answers
| Question | Answer | Explanation |
|---|---|---|
| Q1 | C | Embryonic firms retain almost all earnings for R&D and expansion; dividend payouts are zero or very low |
| Q2 | B | Higher supplier concentration increases supplier power, strengthening one of the five forces and lowering long-run ROE |
| Q3 | B | g = 18 % × (1 – 0.3) = 12.6 % |
| Q4 | A | Faster-growing firms deserve higher EV/EBITDA multiples than mature peers |
| Q5 | B | The defining test of a moat is the ability to sustain ROE meaningfully above cost of capital for many years |
| Q6 | B | Calculated equity value ≈ 63.2; trailing P/E = 63.2 / 4 ≈ 15.8× |
| Q7 | D | Embryonic firms normally pay zero or very low dividends to conserve cash for growth |
| Q8 | B | Strong buyer power enables price concessions that directly compress gross margins |
Takeaways
- Industry analysis requires simultaneous use of life-cycle stage, Porter’s Five Forces, and moat assessment.
- ROE is attractive only when it exceeds WACC and is sustainable.
- The sustainable growth rate is the key benchmark for assessing whether reported growth is healthy.
- Valuation multiples must be adjusted for life-cycle differences; direct comparison across stages is a common trap.
- Ratio analysis must examine trends, peer benchmarks, and consistency with the firm’s life-cycle position.
- A true economic moat is defined by long-term ability to earn returns above the cost of capital, not merely high current margins.